Search results
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 2 days agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
Q1 2024 BioNTech SE Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoParticipants Jens H. Holstein; CFO & Member of Management Board; BioNTech SE Ozlem Tureci; Co-Founder, Chief Medical Officer & Member of Management Board; BioNTech ...
BioNTech Seesaws On Wide Losses, Continuing Covid Slump
Investor's Business Daily· 2 days agoSales of Comirnaty, the BioNTech-Pfizer (PFE)-partnered Covid shot, plummeted 86% to $202 million,...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 2 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
Kestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoKestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the 4th quarter, according to the company in its most recent ...
AstraZeneca asks for European authorisation of COVID vaccine to be pulled
Euronews via Yahoo News· 6 hours agoBillions of doses of the AstraZeneca vaccine were distributed to poorer countries through a...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 2 days ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 3 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks via Yahoo Finance· 5 days agoInvestors are always looking for stocks that are poised to beat at earnings season and BioNTech SE...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
